CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:CNTB • KYG235491019

2.4 USD
-0.15 (-5.88%)
At close: Jan 30, 2026
2.16 USD
-0.24 (-10%)
After Hours: 1/16/2026, 8:02:09 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CNTB. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 8.06. This target is 235.75% above the current price.
  • CNTB was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CNTB.
  • In the previous month the buy percentage consensus was at a similar level.
  • CNTB was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

CNTB Historical Analyst RatingsCNTB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -56 -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.406.067.658.0610.50 - 152.50% 218.75% 235.75% 337.50%

Related screens

CNTB Current Analyst RatingCNTB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-12-01 Lake Street Initiate Buy
2025-11-13 BTIG Reiterate Buy -> Buy
2025-10-31 BTIG Initiate Buy
2025-08-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-17 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-04 HC Wainwright & Co. Initiate Buy
2023-09-13 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-02-08 SVB Leerink Maintains Outperform
2022-06-02 Cantor Fitzgerald Initiate Overweight
2022-05-05 Piper Sandler Downgrade Overweight -> Neutral
2022-05-04 SVB Leerink Maintains Outperform
2022-01-06 SVB Leerink Maintains Outperform
2021-07-02 CICC Initiate Outperform
2021-04-13 SVB Leerink Initiate Outperform
2021-04-13 Jefferies Initiate Buy

CONNECT BIOPHARMA HOLDINGS L / CNTB FAQ

What do analysts expect the price target to be for CONNECT BIOPHARMA HOLDINGS L (CNTB)?

11 analysts have analysed CNTB and the average price target is 8.06 USD. This implies a price increase of 235.75% is expected in the next year compared to the current price of 2.4.


Can you provide the consensus rating for CONNECT BIOPHARMA HOLDINGS L stock?

The consensus rating for CONNECT BIOPHARMA HOLDINGS L (CNTB) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for CNTB stock?

The number of analysts covering CONNECT BIOPHARMA HOLDINGS L (CNTB) is 11.